Resources
11 Results (showing 1 - 10)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 3/28/2024 (updated 4/4/2024)
This workshop focused on how to find public transportation and how to communicate with public transportation organizations in your community. Through clarifying your needs and collaborating on options, you may find shared interests and ideas to improve services for your client access to food, jobs, education, and treatment.
Posted 4/3/2020 (updated 3/28/2024)
This RSV Breakout Session was held in the Independence Ballroom on Wednesday, March 5, 2020, at 2:30 PM
Posted 4/3/2020 (updated 3/28/2024)
This RSV Breakout Session was held in the Treasury Room on Wednesday, March 4, 2020, at 4:15 PM
RSV 2023 Session: Quick Response Teams: Preventing Deaths While Sharing the Hope of Recovery (Day 1)
Posted 7/26/2023 (updated 3/28/2024)
The presentation discussed the development and changes in the utilization of a Quick Response Team in an Ohio rural community.
Posted 7/26/2023 (updated 3/28/2024)
RSV 2023: 9:00 - 10:45 a.m. Welcome and Keynote Address (Day 1)
Posted 6/7/2022 (updated 3/27/2024)
Public transit and health care should be closely linked. Often that is not happening. This session addressed how community partnerships between the health care and transportation sectors develop and can be encouraged.
Posted 6/3/2022 (updated 3/27/2024)
This presentation highlighted The Health Wagon’s Rural Communities Opioid Response program, Strengthening and Expanding Substance Use Disorder and Opioid Use Disorder Prevention, Treatment and Recovery Programs in Southwest Virginia. The program is a consortium-based implementation that aims to reduce the morbidity and mortality of substance use disorder (SUD), including opioid use disorder (OUD), in rural communities in Southwest Virginia at the highest risk for SUD.
Posted 4/4/2023 (updated 3/27/2024)
The U.S. Food and Drug Administration (FDA) announced that the makers of Narcan, an opioid overdose treatment, have the agency’s approval to make the drug widely available over the counter (OTC). Narcan is the brand name of the drug naloxone, a fast-acting overdose reversal. Until now, availability varied by state – typically restricted to licensed health care providers, approved opioid overdose programs, and first responders. This is an important consideration for rural counties given that research shows that these areas are nearly three times more likely than metropolitan counties to be a low-dispensing county for naloxone.
Posted 6/10/2022 (updated 3/27/2024)
During this session, we discussed what meaningful inclusion is (and is not) and we offered tangible steps toward developing trust, dignity, and inclusion of PWUDs. Meeting people where they are requires an element of internal self-reflection and honesty, both personally and within the organization.
Posted 7/31/2023 (updated 3/26/2024)
At the end of July 2023, the U.S. Food and Drug Administration approved a second over-the-counter naloxone nasal spray product, RiVive. The agency who received the approval to manufacture the product, Harm Reduction Therapeutics, does not yet have a timeline of availability and decision on pricing.